Abstract. The enzyme myo-Inositol oxygenase (MIOX) is also termed ALDRL6. It is a kidney-specific member of the aldo-keto reductase family. MIOX catalyzes the first reaction involved in the myo-inositol metabolism signaling pathway and is fully expressed in mammalian tissues. MIOX catalyzes the oxidative cleavage of myo-Inositol and its epimer, D-chiro-Inositol to D-glucuronate. The dioxygen-dependent cleavage of the C6 and C1 bond in myo-Inositol is achieved by utilizing the Fe 2+ /Fe 3+ binuclear iron center of MIOX. This enzyme has also been implicated in the complications of diabetes, including diabetic nephropathy. The MIOX gene was amplified with reverse transcription-polymerase chain reaction from baboon tissue samples, and the product was cloned and sequenced. MIOX expression in the baboon kidney is described in the present study. The percentages of nucleotide and amino acid similarities between baboons and humans were 95 and 96%, respectively. The MIOX protein of the baboon may be structurally identical to that of humans. Furthermore, the evolutionary changes, which have affected these sequences, have resulted from purifying forces.
Introduction
In mammalian cells, the only pathway for inositol breakdown is via myo-Inositol oxygenase (MIOX) (1) . MIOX is a non-heme iron enzyme, which performs the conversion of myo-Inositol to glucuronic acid, the first committed step in myo-Inositol catabolism (2, 3) . The reaction involves oxidative cleavage of the bond between C6 and C1 to produce D-glucuronic acid. D-glucuronic acid is successively converted to L-gulonate, 3-keto-L-gulonate, L-xylulose, xylitol, D-xylulose and D-xylulose-5-phosphate, which then enters the pentose phosphate cycle (4) . MIOX is predominantly expressed in the renal tubules, but is also observed at lower levels in extra-renal tissues, where diabetic complications are widely shown (3) . Altered inositol metabolism is implicated in a number of diabetic complications, including cataracts, nephropathy, retinopathy and neuropathy. MIOX enzymatic activity is proportional to its serum glucose concentration (5) . In addition, there is evidence that a polymorphism (rs761745) in the promoter region of the MIOX gene is associated with the progress of type 1 diabetes mellitus (1,6). RAFAEL GONZÁLEZ-ÁLVAREZ   1   , DIANA CRISTINA PÉREZ-IBAVE   2   , MARÍA LOURDES GARZA-RODRÍGUEZ  3 ,   ÁNGEL LUGO-TRAMPE  4 , IVÁN DELGADO-ENCISO  5 , MARÍA ELIZABETH TEJERO-BARRERA   6   ,  LAURA ELIA MARTÍNEZ-DE-VILLARREAL  7 , RAQUEL GARZA-GUAJARDO  8 ,   MARÍA MARISELA SÁNCHEZ-CHAPARRO  7 , GABRIEL RUIZ-AYMA  9 ,   ORALIA BARBOZA-QUINTANA  8 , HUGO ALBERTO BARRERA-SALDAÑA  3 , MARÍA DEL REFUGIO ROCHA-PIZAÑA 10 and IRÁM PABLO RODRÍGUEZ-SÁNCHEZ
Molecular cloning of the myo-inositol oxygenase gene from the kidney of baboons
The structure of the MIOX gene has been characterized in humans and other mammals, including mice and rats, and MIOX sequences for cows, wild boars, dogs, orangutans, rhesus monkeys, common marmosets, bonobos, northern greater galagos, and Tasmanian devils are reported in GenBank (2, 4, 7) .
In humans, the MIOX gene is located on chromosome 22 in band 22q13.3, and consists of a DNA coding sequence (CDS) of 858 nucleotides (nt) split by 11 introns (exon 1,15 nt; exon 2,81 nt; exon 3,81 nt; exon 4,163 nt; exon 5,68 nt; exon 6,110 nt; exon 7,68 nt, exon 8,50 nt; exon 9,113 nt; and exon 10,109 nt). The open reading frame (ORF) encodes a polypeptide of 285 amino acid residues with a mass of 33.01 kDa (8) .
Although the function of the MIOX enzyme in human physiology has been determined, there are few MIOX-associated studies (8) . Currently, there are gaps in the genomic information of MIOX in experimental animal models; thus, characterizing the physiological differences between humans and other MIOX proteins is difficult. An animal model closely associated with humans was selected in the current study. The current study describes the gene encoding MIOX in the baboon (Papio hamadryas). It is hypothesized that the baboon is an ideal animal model due to the fact that baboons spontaneously develop type 1 and 2 diabetes, which is considered to be a physiological research advantage.
Materials and methods
Animal specimens and nucleic acid isolation from biological samples. Samples from three male baboons were collected from the following frozen archived tissues: Testis, kidney, heart, omental fat, skeletal muscle, pancreas, mononuclear cells, liver and hypothalamus. The samples were collected according to ethical guidelines reviewed by the Institutional Animal Care and Use Committee of the Texas Institute of Biomedical Research (TIBR) (San Antonio, TX, USA). The animals had been housed at the Southwest National Primate Research Center at TIBR and were sacrificed under humanitarian conditions. All of the baboons were housed together and fed ad libitum on standard low-fat chow (15% Monkey Diet, 8715; Harlan Teklad Labs, Houston, TX, USA).
Total RNA was isolated from the tissue samples using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA), according to the manufacturer's instructions. The RNA samples were treated with DNaseI (Invitrogen; Thermo Fisher Scientific, Inc.) for 10 min at 37˚C to remove any remainder of genomic DNA. The quality and integrity of the RNA were evaluated using standard spectrophotometric and electrophoretic methods, respectively.
Reverse transcription (RT) and polymerase chain reaction (PCR) amplification.
The RT reactions were developed with 1 µg total RNA using random primers and a high-capacity cDNA RT kit (Applied Biosystems; Thermo Fisher Scientific, Inc.), according to the manufacturer's instructions. To amplify the baboon MIOX cDNA with PCR, 2X Taq PCR Master Mix (Qiagen, Inc., Valencia, CA, USA) was used, 5 µl synthesized cDNA served as the template, and 10 pM of each consensus primer (forward, 5'-TATAGGAGCCTGGCTG AGGA-3' and reverse, 5'-CAGGCCTAGGTCCAGCAG-3'), designed based on previously reported, highly conserved primate MIOX sequences with the online UniPrime2 tool http://uniprime.batlab.eu (9) . The complete MIOX CDS was amplified (based on the human MIOX gene sequence). The PCR thermal cycling program included initial denaturation at 94˚C for 3 min, followed by 28 cycles of denaturation at 94˚C for 30 sec, annealing at 59˚C for 35 sec, and elongation at 72˚C for 45 sec, with a final elongation at 72˚C for 6 min. Universal β-actin gene primers (Ambion; Thermo Fisher Scientific, Inc.) were used to amplify the positive control. All PCR amplification products were The electropherograms were analyzed with the GeneStudio Pro tool (GeneStudio, Inc., Suwanee, GA, USA). The DNA sequences of the MIOX transcripts were used to deduce the amino acid sequences using the Transeq online softwa http:// www.ebi.ac.uk/Tools/st/emboss_transeq/ (10), and these were subsequently aligned with other MIOX sequences using the ClustalW program (11) . All procedures were performed with three clones of each amplicon to exclude artifacts.
Phylogenetic analysis. The data obtained from the sequencing analysis were used as the target sequence in a Basic Local Alignment Search Tool search to determine the identity. The sequences were subsequently aligned using the ClustalW program http://www.ebi.ac.uk/Tools/msa/clustalw2 (11) . The GenBank accession numbers of the sequences used in the current study are presented in Table I . A phylogenetic tree was constructed from the mRNA sequences using MEGA version 6 software (12) with the neighbor-joining method (13) with 1,000 bootstrap replications (14) . To identify the evolutionary forces underlying the divergence in the primate MIOX genes, the synonymous (dS; encoded amino acid does not change) and non-synonymous (dN; the encoded amino acid changes) substitutions were quantified using the modified Nei-Gojobori method (15) , and the MIOX CDs from apes, Old World monkeys (OWMs) and New World monkeys (NWMs), with the lemur counterpart sequence as the out-group. The hypothesis of positive or adaptive evolution (dN>dS), purifying selection (dN<dS) and neutrality (dN=dS) was then tested using a codon-based Z test of selection (16) , which is included in the MEGA version 6 software (12). P<0.05 was considered to indicate a statistically significant difference.
Results

Molecular biology.
A single band of the expected size (858 bp) was amplified by RT-PCR from renal tissue cDNA. This amplicon was not observed in the other tissue samples (testis, heart, omental fat, skeletal muscle, pancreas, mononuclear cells, liver or hypothalamus) that were analyzed. Thus, the MIOX transcript was only observed in the kidney. The novel sequence was deposited in the GenBank database (accession no. KP299165).
The nucleotide and amino acidic sequences of baboon MIOX were compared with their human counterparts. The percentage nucleotide similarity between the baboon and human genes was 95% and the percentage amino acid identity between the proteins was 96%. In total, 10 amino acid changes were identified between the two primate species. Thorsell et al (1) proposed a novel role for Lys127 (K127) in the crystallized human MIOX protein in controlling access to the diiron cluster. That position is conserved in the baboon enzyme as predicted from the ORF. In our previous study, it was found that, in the active site of the baboon MIOX enzyme, the diiron cluster is bound in a conserved crevice formed between α4, α5, α6, α7 and α8 (17) . This represents a strictly conserved diiron cluster with a first coordination sphere of four histidines (H98, H123, H194 and H220) and two aspartates (D124 and D253) (1). All these positions are conserved in the baboon MIOX protein (Fig. 1) .
Phylogenetic analysis. Apes, OWMs and NWMs demonstrated a clear tendency toward purifying selection (dN<dS; P= 0.0001). A screening test was performed using Fisher's exact test selection with the models of Nei-Gojobori, Li-Wu-Luo, Pamilo-Bianchi-Li and Kumar. The same results were obtained with all the models used (Table II) .
Statistical analysis. Statistical and mathematical calculations made in this work were performed using different algorithms of the MEGA software. Although there are many mathematical algorithms, none is better than another, they simply start from different assumptions. These algorithms are known and accepted among the expert community in the subject. The phylogenetic tree constructed from primate MIOX sequences (Fig. 2) shows four lineage-specific clades, corresponding to apes, OWMs, NWMs and lemurs (out-group). It supports the orthology within the primate MIOX genes. Bootstrap values are shown on the branches of the tree. Approaching results were obtained with other phylogenetic methods.
Discussion
Molecular biology. The MIOX sequence in baboons was observed to be highly similar to that of other apes. The preservation of exon-intron limits and the lack of evident mutations indicate that the baboon MIOX gene is functional. To the best of our knowledge, this is the first study that reports the expression profile of the novel MIOX gene in different tissues from baboons. The results of the current study indicate that, in baboons, the MIOX gene is only expressed in the kidney, while in humans, MIOX gene expression is observed in kidney and extrarenal tissue (3). To elucidate this difference, further studies are required, which include promoter alignment, bioinformatics analyses (in order to predict transcriptional factor binding sites) and searching CpG islands that are susceptible to methylation. Conservation of the structural amino acid (lysine 127), histidines (98, 123, 194 and 220) and aspartates (124 and 253) (1), suggests that the three-dimensional shape may be identical in baboon and human MIOX protein (Fig. 1) . Kidney expression in the two species suggests that the machinery, which regulates gene expression is similar in humans and baboons. In addition, it indicates that the MIOX gene may exert a similar physiological impact. However, further studies under different physiological conditions, such as insulin resistance, diabetes, obesity, fasting or other conditions associated with metabolic syndrome, are required.
Phylogenetic analysis. Positive selection (dN>dS) means that non-synonymous substitutions are functional and profitable to the organism, and provide an evolutionary benefit. While purifying selection (dN<dS) implies that evolutionary pressure eases off. The dN and dS rates were estimated in the present study and it was found that the evolutionary force that acts is purifying selection (Table II) . Thus, it was hypothesized that purifying selection is an indication that the MIOX gene is functional in the studied species, as functional family genes fit this hypothesis. In conclusion, only one MIOX gene was found for baboons and splicing variants were not detected. Furthermore, MIOX gene expression was only identified in the kidney. The dN and dS rates conclusively demonstrated that MIOX genes are included in the hypothesis of purifying selection.
